Lisata Therapeutics (LSTA) Earnings Date, Estimates & Call Transcripts

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)

Free LSTA Stock Alerts

$2.78

-0.06 (-2.11%)

(As of 04/17/2024 ET)

Compare

Upcoming Earnings Date: May. 14Estimated
Actual EPS (Feb. 29): -$0.66 Beat By $0.20
Consensus EPS (Feb. 29): -$0.86

Earnings Per Share Revenue

LSTA Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

LSTA Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

Lisata Therapeutics Analyst EPS Estimates

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2024	1	($0.74)	($0.74)	($0.74)
Q2 2024	1	($0.74)	($0.74)	($0.74)
Q3 2024	1	($0.73)	($0.73)	($0.73)
Q4 2024	1	($0.73)	($0.73)	($0.73)
FY 2024	4	($2.94)	($2.94)	($2.94)

LSTA Earnings Date and Information

Lisata Therapeutics last released its quarterly earnings results on February 29th, 2024. The reported ($0.66) EPS for the quarter, beating the consensus estimate of ($0.86) by $0.20. Lisata Therapeutics has generated ($2.58) earnings per share over the last year (($2.58) diluted earnings per share). Earnings for Lisata Therapeutics are expected to grow in the coming year, from ($3.08) to ($2.68) per share. Lisata Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 14th, 2024 based off prior year's report dates.

Lisata Therapeutics Earnings History by Quarter

Time Frame

Start Date

End Date

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
5/14/2024 Estimated)	-	-	-	-	-	-	-
2/29/2024	Q4 2023	($0.86)	($0.66)	+$0.20	($0.66)	-	-
11/2/2023	Q3 2023	($0.93)	($0.65)	+$0.28	($0.65)	-	-
8/14/2023	Q2 2023	($0.70)	($0.50)	+$0.20	($0.50)	-	-
5/9/2023	Q1 2023	($0.81)	($0.77)	+$0.04	($0.77)	-	-
3/30/2023	Q4 2022	($0.96)	($0.76)	+$0.20	($0.76)	-	-
11/10/2022	Q3 2022	($0.90)	($1.48)	($0.58)	$4.92	-	-
Get the Latest News and Ratings for LSTA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Lisata Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
8/4/2022	Q2 2022	($1.50)	($1.65)	($0.15)	($1.65)	-	-
5/5/2022	Q1 2022	($1.50)	($1.05)	+$0.45	($1.05)	-	-
3/22/2022	Q4 2021	($2.25)	($1.65)	+$0.60	($1.65)	-	-
11/4/2021	Q3 2021	($1.95)	($1.80)	+$0.15	($1.80)	-	-
8/5/2021	Q2 2021	($2.25)	($1.50)	+$0.75	($1.50)	-	-
5/6/2021	Q1 2021	($1.35)	($2.85)	($1.50)	($2.85)	-	-

Lisata Therapeutics Earnings - Frequently Asked Questions

When is Lisata Therapeutics's earnings date?: Lisata Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 14th, 2024 based off last year's report dates. Learn more on LSTA's earnings history.
Did Lisata Therapeutics beat their earnings estimates last quarter?: In the previous quarter, Lisata Therapeutics (NASDAQ:LSTA) reported ($0.66) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.86) by $0.20. Learn more on analysts' earnings estimate vs. LSTA's actual earnings.
How much profit does Lisata Therapeutics generate each year?: Lisata Therapeutics (NASDAQ:LSTA) has a recorded net income of -$20.84 million. LSTA has generated -$2.58 earnings per share over the last four quarters.
What is Lisata Therapeutics's EPS forecast for next year?: Lisata Therapeutics's earnings are expected to grow from ($3.08) per share to ($2.68) per share in the next year.

More Earnings Resources from MarketBeat

Related Companies:

Earnings Tools:

Earnings By Country:

Latest Articles:

This page (NASDAQ:LSTA) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Lisata Therapeutics (LSTA) Earnings Date, Estimates & Call Transcripts

LSTA Earnings Estimates and Actuals by Quarter

LSTA Estimated and Actual Revenue by Quarter

Lisata Therapeutics Analyst EPS Estimates

LSTA Earnings Date and Information

Lisata Therapeutics Earnings History by Quarter

Lisata Therapeutics Earnings - Frequently Asked Questions

More Earnings Resources from MarketBeat

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Lisata Therapeutics (LSTA) Earnings Date, Estimates & Call Transcripts

Earnings Summary

LSTA Earnings Estimates and Actuals by Quarter

LSTA Estimated and Actual Revenue by Quarter

Lisata Therapeutics Analyst EPS Estimates

LSTA Earnings Date and Information

Lisata Therapeutics Earnings History by Quarter

Lisata Therapeutics Earnings - Frequently Asked Questions

More Earnings Resources from MarketBeat